Inhalant dependence
ICD-10 F18.2 is a billable code used to indicate a diagnosis of inhalant dependence.
Inhalant dependence is characterized by a compulsive pattern of inhalant use leading to significant impairment or distress. Inhalants are volatile substances that produce chemical vapors, which can be inhaled to induce psychoactive effects. Common inhalants include solvents, aerosols, and gases found in household products. Dependence on inhalants can manifest through a range of symptoms, including cravings, tolerance, and withdrawal symptoms when not using the substance. Withdrawal may present with symptoms such as irritability, anxiety, sleep disturbances, and physical symptoms like tremors. The condition is often associated with various psychosocial issues, including behavioral problems, academic difficulties, and social isolation. Treatment typically involves behavioral therapies, counseling, and support groups, as there are no specific pharmacological treatments approved for inhalant dependence. Early intervention is crucial to prevent long-term health consequences, including neurological damage and other serious health issues.
Detailed history of substance use, including types of inhalants, frequency, and duration of use.
Patients presenting with acute intoxication or withdrawal symptoms, or those seeking treatment for inhalant dependence.
Consideration of co-occurring mental health disorders and the need for a multidisciplinary treatment approach.
Comprehensive psychiatric evaluation including mental status examination and assessment of substance use impact on mental health.
Patients with inhalant dependence presenting with anxiety, depression, or other psychiatric symptoms.
Importance of documenting any psychiatric comorbidities and their treatment.
Used during initial evaluation of a patient with suspected inhalant dependence.
Comprehensive assessment notes detailing substance use history and current symptoms.
Addiction specialists should ensure thorough documentation of all substance use.
Primary symptoms include cravings for inhalants, tolerance to their effects, withdrawal symptoms such as irritability and anxiety, and significant impairment in social, occupational, or other important areas of functioning.
